| Author (Corporate) | European Medicines Agency |
|---|---|
| Publisher | EC |
| Publication Date | 2010 |
| Content Type | Report |
|
This paper reviews approaches for balancing benefits and risks in decision making about medicinal products. Its publication represents the finalisation of the second step of the Agency’s five-step project, which aims to make its decision-making on the benefits and risks of medicines more transparent, more consistent and easier to audit. |
|
| Source Link | Link to Main Source http://www.ema.europa.eu/docs/en_GB/document_library/Report/2010/10/WC500097750.pdf |
| Related Links |
|
| Subject Categories | Health |
| Countries / Regions | Europe |